HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of alpha2 beta1 and alpha3 beta1 integrin receptors in the initial anchoring of MDA-MB-231 human breast cancer cells to cortical bone matrix.

Abstract
Molecular mechanisms involved in the rapid attachment of the human breast cancer cell line MDA-MD-231 to cortical bone matrix were studied. The attachment of MDA-MD-231 cells to cortical bone disks could be blocked by 75% when cells were pretreated with a monoclonal antibody to the beta1-subunit of the integrin family. Monoclonal antibodies against the alpha2, alpha3, and alpha5 integrin subunits inhibited the attachment by 76, 26, and 8 % respectively. Collagenase type I and collagen type I antibody blocked the cell attachment by 45 and 50 % whereas pretreatment of the cells with soluble collagen type I blocked the attachment by 85 %. Our study with a panel of cancer cell lines further showed a close correlation between alpha2 beta1 and alpha3 beta1 integrin receptor expression and the capability to attach to cortical bone. These receptors appear to be the key receptors utilized by cancer cells for the initial attachment to cortical bone, and this could facilitate the localization of alpha2 beta1 and alpha3 beta1 expressing cancer cells to the skeleton.
AuthorsA Lundström, J Holmbom, C Lindqvist, T Nordström
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 250 Issue 3 Pg. 735-40 (Sep 29 1998) ISSN: 0006-291X [Print] United States
PMID9784415 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 1998 Academic Press.
Chemical References
  • Integrin alpha3beta1
  • Integrins
  • Receptors, Collagen
  • Collagenases
Topics
  • Animals
  • Bone Matrix (pathology)
  • Breast Neoplasms (pathology)
  • Cattle
  • Cell Adhesion (drug effects, physiology)
  • Collagenases (pharmacology)
  • Female
  • Humans
  • Integrin alpha3beta1
  • Integrins (physiology)
  • Receptors, Collagen
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: